Dolan Daniel 4
4 · Nabriva Therapeutics plc · Filed Apr 2, 2021
Insider Transaction Report
Form 4
Dolan Dan
Chief Financial Officer
Transactions
- Award
Stock Option
2021-03-31+100,000→ 100,000 totalExercise: $1.66Exp: 2031-03-30→ Ordinary Shares (100,000 underlying)
Footnotes (2)
- [F1]The option was granted on March 31, 2021.
- [F2]The option will vest over a four-year period. Twenty-five percent (25%) of the option will vest on the one (1)-year anniversary of the date of grant, and the remaining seventy-five percent (75%) of the option will vest on an annual pro-rata basis over the remaining vesting period.